Symptomer og diagnostikk av koronarsykdom hos kvinner

Tidsskrift for den Norske Laegeforening

Volumn 129, Issue 18, 2009, Pages 1853-1857

  Halvorsen, Sigrun ^a   Risøe, Cecilie ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CORONARY ARTERY DISEASE; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; RADIOGRAPHY; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SEXUAL DEVELOPMENT;

AGE FACTORS; ANGINA PECTORIS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; SEX FACTORS;

EID: 70350511758     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.0115     Document Type: Article

References (39)

1. Statistisk sentralbyrå. Dødsårsaker. www.ssb.no/ dodsarsak/ (7.5.2009).
2. Anand SS, Islam S, Rosengren A et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008; 29: 932-40.
3. Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet 1998; 351: 1425-7.
4. Shaw LJ, Bairey Merz CN, Pepine CJ et al. Insights from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study. Part I. J Am Coll Cardiol 2006; 47: 4-20S.
5. Njølstad I, Arnesen E, Lund-Larsen PG. Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women. A 14-year follow-up of the Finnmark Study. Circulation 1996; 94: 2877-82.
6. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332: 73-8.
7. Dale AC, Nilsen TI, Vatten L et al. Diabetes mellitus and risk of fatal ischaemic heart disease by gender. Eur Heart J 2007; 28: 2924-9.
8. van Halm VP, Peters MJ, Voskuyl AE et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease, a cross sectional study. The CARRE Investigation. Ann Rheum Dis 2009; 68: 1395-400.
9. Hochman JS, Tamis JE, Thompson TD et al. Sex, clinical presentation and outcome in patients with acute coronary syndromes. N Engl J Med 1999; 341: 226-32.
10. Rosengren A, Wallentin L, Gitt AK et al. Sex, age and clinical presentation of acute coronary syndromes. Eur Heart J 2004; 25: 663-70.
11. Hemingway H, McCallum A, Shipley M et al. Incidence and prognostic implications of stable angina pectoris among women and men. JAMA 2006; 295: 1404-11.
12. Fox K, Garcia MA, Ardissino D et al. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27: 1341-81.
13. Milner KA, Funk M, Richards S et al. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol 1999; 84: 396-9.
14. Miller CL. A review of symptoms of coronary artery disease in women. J Adv Nurs 2002; 39: 17-23.
15. DeVon HA, Ryan CJ, Ochs AL et al. Symptoms across the continuum of acute coronary syndromes: differences between women and men. Am J Crit Care 2008; 17: 14-24.
16. Milner KA, Vaccarino V, Arnold AL et al. Gender and age differences in chief complaints of acute myocardial infarction. Am J Cardiol 2004; 93: 606-8.
17. Canto JG, Goldberg RJ, Hand MM et al. Symptom presentation of women with acute coronary syndromes: myth vs reality. Arch Intern Med 2007; 167: 2405-13.
18. McSweeney JC, Cody M, O'Sullivan P et al. Women's early warning symptoms of acute myocardial infarction. Circulation 2003; 108: 2619-23.
19. Nau DP, Ellis JJ, Kline-Rogers EM et al. Gender and perceived severity of cardiac disease: Evidence that women are «tougher». Am J Med 2005; 118: 1256-61.
20. European Society of Cardiology. SCORE risk charts. www.escardio.org/Policy/prevention/tools/health-toolkit/Pages/SCORE-Risk-Charts.aspx (7.5.2009).
21. Selmer R, Lindman AS, Tverdal A et al. Modell for estimering av kardiovaskulær risiko i Norge. Tidsskr Nor Legeforen 2008; 128: 286-90.
22. Helsedirektoratet. Nasjonale retningslinjer for individuell primærforebygging av hjerte- og karsykdommer. IS-1550. www.helsedirektoratet.no/kvalitetsforbedring/retningslinjer_veiledere/publiserte (7.5.2009).
23. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006; 145: 21-9.
24. Ridker PM, Buring JE, Rifai N et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007; 297: 611-9.
25. Kablak-Ziembicka A, Przewlocki T, Tracz W et al. Gender differences in carotid intima-media thickness in patients with suspected coronary artery disease. Am J Cardiol 2005; 96: 1217-22.
26. Stangl V, Witzel V, Baumann G et al. Current diagnostic concepts to detect coronary artery disease in women. Eur Heart J 2008; 29: 707-17.
27. Mieres JH, Shaw LJ, Arai A et al. Role of non-invasive testing in the clinical evaluation of women with suspected coronary artery disease. Circulation 2005; 111: 682-96.
28. Kwok YS, Kim C, Grady D et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999; 83: 660-6.
29. Marcassa C, Bax JJ, Bengel F et al. Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement. Eur Heart J 2008; 29: 557-63.
30. Kim C, Kwok YS, Heagerty P et al. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis. Am Heart J 2001; 142: 934-44.
31. Schannwell CM, Lazica D, Plehn G et al. The current status of noninvasive cardiac diagnosis in women with suspected coronary heart disease. Med Klin (Munich) 2002; 97: 513-21.
32. Mora S, Redberg RF, Cui Y et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA 2003; 290: 1600-7.
33. Swahn E, Alfredsson J, Afzal R et al. Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials. Eur Heart J 2009; e-publisert 7.2.2009.
34. Wallentin L, Lagerqvist B, Husted S et al. Outcome at 1 year after an invasive compared with a noninvasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast revascularisation during instability in coronary artery disease. Lancet 2000; 356: 9-16.
35. Daly C, Clemens F, Lopez Sendon JL et al. Gender differences in the management and clinical outcome of stable angina. Circulation 2006; 113: 490-8.
36. Pepine CJ, Kerensky RA, Lambert CR et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol 2006; 47: 30-5S.
37. Bugiardini R, Bairey Merz CN. Angina with «normal» coronary arteries: a changing philosophy. JAMA 2005; 293: 477-84.
38. Schroeder S, Achenbach S, Bengel F et al. Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a writing group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. Eur Heart J 2008; 29: 531-56.
39. Klem I, Greulich S, Heitner JF et al. Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. JACC Cardiovasc Imaging 2008; 1: 436-45.